Related Experiment Videos
Temporal hypometabolism at the onset of cryptogenic temporal lobe epilepsy
P Matheja1, T Kuwert, P Lüdemann
1Department of Nuclear Medicine, Münster University, Germany. matheja@uni-muenster.de
Abstract:
Most patients with intractable temporal lobe epilepsy (TLE) exhibit temporal glucose hypometabolism. The reasons for the development of this abnormality are as yet unclear. The current notion is that an initial injury causes seizures, which in turn give rise to hypometabolism. The aim of this study was to assess whether temporal reductions in glucose metabolism in non-lesional TLE are the result of repeated seizures or whether hypometabolism represents an initial disturbance at the onset of disease. Glucose consumption was assessed with fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG PET) in 62 patients with cryptogenic non-refractory TLE in different stages of disease. Twelve subjects without neurological illness served as controls. Patients with onset of epilepsy at least 3 years prior to the PET scan were defined as having chronic TLE. Using this criterion, the whole patient cohort included 27 patients with de novo TLE and 35 patients with chronic TLE. The groups were matched for age and sex. The appearance of high-resolution magnetic resonance images of the brain was unremarkable in all patients. In the total cohort, number, duration and frequency of seizures had a significant relation to the magnitude of hypometabolism. Temporal hypometabolism was exhibited by 26 of the 62 patients (42%), including 8 out of 27 (30%) with newly diagnosed TLE and 18 out of 35 (51%) with chronic TLE. The disturbances were more extensive and more severe in patients with chronic TLE. It is concluded that temporal hypometabolism may already be present at the onset of TLE, but is less frequent and less severe in newly diagnosed than in chronic TLE. The metabolic disturbance correlates with the number of seizures. These findings suggest that an initial dysfunction is present in a considerable number of patients and that hypometabolism is worsened by continuing epileptic activity.
Insights
Temporal lobe epilepsy (TLE) patients often show reduced brain glucose metabolism. This study found that while seizures worsen hypometabolism, an initial metabolic disturbance may be present at TLE onset.
Area of Science:
- Neuroscience
- Epilepsy Research
- Medical Imaging
Background:
- Intractable temporal lobe epilepsy (TLE) frequently presents with temporal glucose hypometabolism.
- The underlying cause of this hypometabolism, whether from seizures or an initial disturbance, remains unclear.
- Current theories suggest seizures lead to hypometabolism, but this study investigates alternative origins.
Purpose of the Study:
- To determine if temporal glucose hypometabolism in non-lesional TLE results from recurrent seizures or represents an early disease manifestation.
- To differentiate between seizure-induced metabolic changes and pre-existing metabolic abnormalities in TLE.
- To assess the relationship between seizure activity and the severity of hypometabolism.
Main Methods:
- Utilized fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG PET) to measure glucose metabolism.
- Studied 62 patients with cryptogenic non-refractory TLE, categorized into de novo (n=27) and chronic (n=35) epilepsy groups.
- Included 12 healthy controls and ensured all TLE patients had unremarkable MRI scans.
Main Results:
- Temporal hypometabolism was observed in 42% of TLE patients (30% de novo, 51% chronic).
- Hypometabolism was more extensive and severe in patients with chronic TLE compared to newly diagnosed cases.
- A significant correlation was found between the number, duration, and frequency of seizures and the magnitude of hypometabolism.
Conclusions:
- Temporal hypometabolism can be present at the onset of TLE, though less frequent and severe in early stages.
- Metabolic disturbances are exacerbated by ongoing epileptic activity, correlating with seizure burden.
- Findings suggest an initial dysfunction in a substantial number of TLE patients, which worsens with continued seizures.